Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

PREVENTION NEWS - Page 9

Top Infectious Disease News of the Week—February 25, 2018
In case you missed them, we’ve compiled the top five infectious disease articles from this past week.
First Global Estimate Reveals 1.8 Million Young Adults Develop TB Annually
The first global estimate of tuberculosis (TB) rates among young people find that about 1.8 million individuals in this age group develop the disease each year.
 
CARB-X Announces Latest Funding for New Antibiotics to Fight Drug-Resistant Bacteria
CARB-X, the international partnership between governmental and charitable groups in the United States and the United Kingdom, has announced new funding for the development of new antibiotics to fight drug-resistant bacteria.
Oral Influenza Vaccine Produces Favorable Results in Phase 2 Trial
The results of the trial revealed that the tablet reduced the rate of infection with influenza by 48%.
NIAID Announces Plan to Make Universal Flu Vaccine A Reality
The institute has made the development of the vaccine “one of its highest priorities.”
Senate Bill Calls for $1 Billion To Go Towards Universal Flu Vaccine Research
A new bill introduced by a group of senators aims to boost universal flu vaccine research by $1 billion over the next 5 years, as health officials continue to investigate the cause of the flu shot’s low efficacy.
CDC Analysis Suggests Fluoroquinolone Prescribing Continues Apace in the US, Despite FDA Warnings: Public Health Watch
High prescribing continues despite the fact that heavy use of these agents can facilitate the development of multidrug-resistant bacteria and tendon, muscle, joint, and central nervous system damage.
Altered Broadly Neutralizing HIV Antibody Potential Major Player in HIV Prevention
NIAID Vaccine Research Center scientists alters broadly neutralizing HIV antibody to make it last longer in the blood.